Notification in terms of S122(3) if the Companies Act and section 3.83(b) of the JSE Listings Requirements
ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049 JSE Code: AVL
NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND SECTION 3.83(B) OF THE JSE
LISTINGS REQUIREMENTS
In accordance with section 122(3)(b) of the Companies Act, 71 of 2008 ("the Act"), and section 3.83(b) of the
JSE Limited Listings Requirements, holders of ordinary shares in the Company are advised Sanlam Investment
Management Proprietary Limited (acting as agent of its clients), have, as a result of the Advanced Health
Rights Offer, acquired and disposed of beneficial interests in ordinary shares of the Company ("the
securities"), such that its shareholding in the securities of the Company currently amounts to 5.93% of the
total number of shares in issue, as at 7 April 2021.
Advanced Health hereby confirms that it has received the required notices from the above named parties in
terms of section 122(3)(a) of the Act, and that it has filed the required notices with the Takeover Regulation
Panel.
Johannesburg
7 April 2021
Designated Advisor
Grindrod Bank Limited
Date: 07-04-2021 04:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.